Drug intelligence / Profile preview

adelmidrol + hyaluronic acid

Development stage
Unknown
Lead developer
Epitech
Modality
Small Molecules
Administration
Intranasal
01

Overview

Rinidrol is an intranasal spray developed by Epitech for the management of pediatric nasal and respiratory conditions, including inflammation and hyper-reactivity of the nasal mucosa. It is a combination product containing **adelmidrol**, a synthetic ALIAmide (Autacoid Local Injury Antagonism) analogue of palmitoylethanolamide, and **hyaluronic acid**. Adelmidrol acts by modulating mast cell degranulation and non-neuronal immune cell activity, thereby reducing local inflammatory responses. Hyaluronic acid provides a protective and hydrating barrier on the nasal mucosa, facilitating tissue repair and improving mucociliary clearance. The product is primarily marketed for pediatric use to treat conditions such as allergic rhinitis and respiratory tract inflammation.

Brand names
RinidrolRinidrol Spray Nasale
Other names
N,N'-bis(2-hydroxyethyl)nonanediamide + sodium hyaluronate
02

Targets

CD44 (CD44 antigen)PPARA (Peroxisome proliferator-activated receptor alpha)PPARG (Peroxisome proliferator-activated receptor gamma)

Beyond the preview

Go deeper on adelmidrol + hyaluronic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on adelmidrol + hyaluronic acid.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call